RESEARCH USE ONLY | Free Shipping Over £140

High Purity

Laboratory Tested

Secure Payments

Bank Transfer & More

Delivery

UK & Europe Wide

Tirzepatide 20mg

Tirzepatide 20mg

£180.00

Overview: Tirzepatide is a cutting-edge research tool designed for the study of metabolic disorders, including type 2 diabetes and obesity. This synthetic peptide mimics the actions of both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), making it a dual agonist with potent effects on glucose regulation and weight loss. Available exclusively for research use, Tirzepatide offers a unique opportunity to explore innovative therapeutic avenues in metabolic disease management.

Key Features:

  • Dual Agonist Mechanism: Tirzepatide’s combined activation of GLP-1 and GIP receptors can lead to improved glycemic control and reduced body weight, offering a multifaceted approach to tackle metabolic diseases.
  • Enhanced Stability and Duration: Designed for increased stability and prolonged activity in physiological conditions, Tirzepatide facilitates extended study periods without frequent re-administration, enhancing research efficacy.
  • Versatile Research Applications: Ideal for investigating the pathophysiology of type 2 diabetes, the mechanisms of bariatric surgery, and potential anti-obesity treatments.
  • High Purity Formulation: Provided as a lyophilized powder that ensures high purity and consistency across experimental batches.
Category Tag

Secure Payment

High Purity

Fast Delivery

  • Description
  • Additional Information
Overview: Tirzepatide is a cutting-edge research tool designed for the study of metabolic disorders, including type 2 diabetes and obesity. This synthetic peptide mimics the actions of both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), making it a dual agonist with potent effects on glucose regulation and weight loss. Available exclusively for research use, Tirzepatide offers a unique opportunity to explore innovative therapeutic avenues in metabolic disease management. Key Features:
  • Dual Agonist Mechanism: Tirzepatide's combined activation of GLP-1 and GIP receptors can lead to improved glycemic control and reduced body weight, offering a multifaceted approach to tackle metabolic diseases.
  • Enhanced Stability and Duration: Designed for increased stability and prolonged activity in physiological conditions, Tirzepatide facilitates extended study periods without frequent re-administration, enhancing research efficacy.
  • Versatile Research Applications: Ideal for investigating the pathophysiology of type 2 diabetes, the mechanisms of bariatric surgery, and potential anti-obesity treatments.
  • High Purity Formulation: Provided as a lyophilized powder that ensures high purity and consistency across experimental batches.
Applications:
  • Diabetes Mellitus Research: Explore the therapeutic potential and underlying mechanisms of Tirzepatide in glucose homeostasis and insulin secretion.
  • Obesity Studies: Utilize Tirzepatide to study its effects on appetite, energy expenditure, and weight loss.
  • Comparative Pharmacology: Assess the differential impacts of GLP-1 and GIP receptor activation in various metabolic and physiological processes.
  • Development of Combination Therapies: Investigate the synergistic effects of Tirzepatide with other therapeutic agents to enhance efficacy in metabolic disorder management.
Specifications:
  • Composition: Synthetic peptide mimicking GLP-1 and GIP
  • Form: Lyophilized powder for reconstitution
  • Purity: >98% as determined by HPLC
  • Packaging: Available in multiple sizes to support both small-scale and bulk research needs
Permission Information: Tirzepatide is intended for research use only, not for human or veterinary use. Handle with appropriate safety measures in a controlled laboratory setting. Conclusion: Tirzepatide represents a state-of-the-art research tool that enables profound insights into the complex interplay of hormonal pathways involved in metabolism. Its dual agonist capabilities make it a valuable asset for the development of next-generation therapies aimed at combating metabolic diseases such as diabetes and obesity. Unlock the potential of Tirzepatide in your research and pave the way for groundbreaking discoveries and therapeutic innovations.